ARCH Venture Management as of March 31, 2022
Portfolio Holdings for ARCH Venture Management
ARCH Venture Management holds 8 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 52.8 | $369M | 2.9M | 126.79 | |
| Eqrx | 21.4 | $150M | 36M | 4.13 | |
| Erasca (ERAS) | 13.6 | $95M | 11M | 8.60 | |
| Verve Therapeutics (VERV) | 8.2 | $57M | 2.5M | 22.82 | |
| Singular Genomics Systems In | 3.4 | $24M | 3.8M | 6.31 | |
| Rubius Therapeutics | 0.3 | $1.9M | 350k | 5.51 | |
| Metacrine Ord | 0.3 | $1.8M | 2.9M | 0.61 | |
| Zymergen | 0.0 | $345k | 119k | 2.89 |
